Brind.

Immuneering, Regeneron Pharmaceuticals, and Eli Lilly signed agreements regarding clinical trials and supply for specific drugs.

1 report, 1 independent Updated Aug 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Immuneering (United States)Regeneron Pharmaceuticals Eli Lilly and Company

Keep exploring

The entities involved

Immuneering (United States)
company in Cambridge, United States

Nothing else this week.
Regeneron Pharmaceuticals
American pharmaceutical company
- Regeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Sun 14:10
Eli Lilly and Company
American pharmaceutical company
- ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
- The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59

Coverage

Newest first; wire copies grouped

Aug 25GlobeNewswireImmuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib - Immuneering to evaluate atebimetinib in combination with olomorasib in planned Pha